Recruiting NA INTERVENTIONAL 1-arm NCT05202678

RECONFIRM - Study of AGN1 LOEP in Patients with Osteoporosis

Prospective, Post-market Evaluation of Safety and Efficacy of a Local Osteo- Enhancement Procedure (LOEP) in the Proximal Femur of Women in Europe with Osteoporosis

Sponsor: AgNovos Healthcare, LLC

Conditions Osteoporosis

Interventions AGN1 LOEP

Updated 6 times since 2022 Last updated: Jan 29, 2025 Started: Jul 5, 2021 Primary completion: Dec 31, 2025 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Osteoporosis and is currently actively recruiting participants. AgNovos Healthcare, LLC leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Feb 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Feb 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Mar 2024 — Jul 2024 [monthly]

Recruiting NA
Dec 2022 — Mar 2024 [monthly]

Recruiting NA

▶ Show 1 earlier version

Feb 2022 — Dec 2022 [monthly]

Recruiting NA

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AgNovos Healthcare, LLC

Data source: AgNovos Healthcare, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sint-Niklaas, Belgium